Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein

References

1. McMillan CLD, Choo JJY, Idris A, Supramaniam A, Modhiran N et al. Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine. Sci Adv 2021; 7:eabj8065 [View Article] [PubMed]
   [Google Scholar]
2. Choo JJY, McMillan CLD, Fernando GJP, Hall RA, Young PR et al. Developing a stabilizing formulation of a live chimeric dengue virus vaccine dry coated on a high-density microarray patch. Vaccines 2021; 9:1301 [View Article] [PubMed]
   [Google Scholar]
3. Choo JJY, Vet LJ, McMillan CLD, Harrison JJ, Scott CAP et al. A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice. NPJ Vaccines 2021; 6:66 [View Article] [PubMed]
   [Google Scholar]
4. Forster AH, Witham K, Depelsenaire ACI, Veitch M, Wells JW et al. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial. PLoS Med 2020; 17:e1003024 [View Article] [PubMed]
   [Google Scholar]
5. Amarilla AA, Sng JDJ, Parry R, Deerain JM, Potter JR et al. A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nat Commun 2021; 12: [View Article]
   [Google Scholar]
6. Depelsenaire ACI, Meliga SC, McNeilly CL, Pearson FE, Coffey JW et al. Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol 2014; 134:2361–2370 [View Article] [PubMed]
   [Google Scholar]
7. Hsieh C-L, Goldsmith JA, Schaub JM, DiVenere AM, Kuo H-C et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 2020; 369:1501–1505 [View Article] [PubMed]
   [Google Scholar]
8. McMillan CLD, Amarilla AA, Modhiran N, Choo JJY, Azuar A et al. Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern. Vaccine 2022; 40:4929–4932 [View Article] [PubMed]
   [Google Scholar]
9. McMillan CLD, Azuar A, Choo JJY, Modhiran N, Amarilla AA et al. Dermal delivery of a SARS-CoV-2 subunit daccine induces immunogenicity against variants of concern. Vaccines 2022; 10:578 [View Article] [PubMed]
   [Google Scholar]
10. Amarilla AA, Modhiran N, Setoh YX, Peng NYG, Sng JDJ et al. An optimized high-throughput immuno-plaque assay for SARS-CoV-2. Front Microbiol 2021; 12:625136 [View Article] [PubMed]
    [Google Scholar]
11. Muller DA, Pearson FE, Fernando GJP, Agyei-Yeboah C, Owens NS et al. Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses. Sci Rep 2016; 6:22094 [View Article] [PubMed]
    [Google Scholar]
12. Choo JJY, McMillan CLD, Young PR, Muller DA. Microarray patches: scratching the surface of vaccine delivery. Expert Rev Vaccines 2023; 22:937–955 [View Article] [PubMed]
    [Google Scholar]
13. Watterson D, Wijesundara DK, Modhiran N, Mordant FL, Li Z et al. Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clin Trans Imm 2021; 10: [View Article]
    [Google Scholar]
14. Depelsenaire ACI, Witham K, Veitch M, Wells JW, Anderson CD et al. Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial. PLoS One 2021; 16:e0255282 [View Article] [PubMed]
    [Google Scholar]
15. Lacaille-Dubois MA. Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: a review. Phytomedicine 2019; 60:152905 [View Article] [PubMed]
    [Google Scholar]